Press Releases from B. Braun Melsungen AG (1 total)
Safety and Efficacy: Paclitaxel-Eluting Balloon SeQuent® Please Shows Positive …
The results of the largest registry about treatment with Drug Eluting Balloons (DEB) were presented last week during the Transcatheter Cardiovascular Therapeutics conference (TCT) in San Francisco. Primary investigator Prof. Dr. Jochen Woehrle from the University of Ulm explained: “The aim of the SeQuent Please World Wide Registry is to assess the safety and efficacy of the paclitaxel-coated SeQuent Please balloon under so called real-world conditions.”
About the Registry
The total enrolled…
